Patents

US 12569553 B2: Shingles vaccines comprising a TLR9 agonist

Granted
2026-03-10
Filed
2021-03-09 application 17910334
Type
Utility · 24 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The present disclosure relates to immunogenic compositions comprising a varicella zoster vims (VZV) glycoprotein E antigen and a toll-like receptor 9 (TLR9) agonist, such as an oligonucleotide comprising an unmethylated cytidine-phospho-guanosine (CpG) motif. The immunogenic compositions are suitable for stimulating an immune response against VZV in an individual in need thereof.

Source: PTBLXML, file of 2026-03-10 (ipgb20260310.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Dynavax Technologies Corporation 50 patentsUS company or organizationEmeryville, CADYNAVAX TECHNOLOGIES CORP SEC filer FUZZY low confidence: same name (legal endings aside), one of each nationallyPTBLXML, file of 2026-03-10

Inventors

InventorPlacePatentsPerson pageSource
John D. CampbellSan Francisco, CA3PTBLXML, file of 2026-03-10
Randall N. HyerGwynedd Valley, PAPTBLXML, file of 2026-03-10
Robert S. JanssenPalm Springs, CAPTBLXML, file of 2026-03-10
David NovackOakland, CA4PTBLXML, file of 2026-03-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K39/25PTBLXML, file of 2026-03-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P31/22PTBLXML, file of 2026-03-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2022-12-15Assignment
Assignment of assignor's interest
CAMPBELL, JOHN D. signed 2021-08-30
HYER, RANDALL N. signed 2021-07-13
JANSSEN, ROBERT S. signed 2021-07-07
NOVACK, DAVID signed 2021-07-07
DYNAVAX TECHNOLOGIES CORPORATION EMERYVILLE, CA62111/498PASDL, file of 2026-10-15

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.